CCDR: Volume 47-3, March 2021: Influenza and Other Respiratory Viruses
The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.
- Publisher
- Public Health Agency of Canada
- Resources
- 18
- Catalogue metadata updated
- 2021-09-27
Data overview
- Formats
- HTML
- File languages
- English, French
Official sources and licences
Resources
- Canadian national COVID-19 genomics surveillance priorities for existing and emerging variants of concern (French, HTML) HTML
- Canadian national COVID-19 genomics surveillance priorities for existing and emerging variants of concern (English, HTML) HTML
- CCDR: Volume 47-3, March 2021: Influenza and Other Respiratory Viruses (French, HTML) HTML
- CCDR: Volume 47-3, March 2021: Influenza and Other Respiratory Viruses (English, HTML) HTML
- Designing tailored interventions to address barriers to vaccination (English, HTML) HTML
- Designing tailored interventions to address barriers to vaccination (French, HTML) HTML
- How COVID-19 vaccines will be regulated for safety and effectiveness (French, HTML) HTML
- How COVID-19 vaccines will be regulated for safety and effectiveness (English, HTML) HTML
- Impact of nonpharmaceutical interventions on laboratory detections of influenza A and B in Canada (French, HTML) HTML
- Impact of nonpharmaceutical interventions on laboratory detections of influenza A and B in Canada (English, HTML) HTML
- Knowledge brokering on infectious diseases for public health (French, HTML) HTML
- Knowledge brokering on infectious diseases for public health (English, HTML) HTML
- Measles surveillance in Canada, 2019 (French, HTML) HTML
- Measles surveillance in Canada, 2019 (English, HTML) HTML
- Seasonality of coronaviruses and other respiratory viruses in Canada: Implications for COVID-19 (English, HTML) HTML
- Seasonality of coronaviruses and other respiratory viruses in Canada: Implications for COVID-19 (French, HTML) HTML
- Vaccine against SARS-CoV-2: Challenges and considerations (French, HTML) HTML
- Vaccine against SARS-CoV-2: Challenges and considerations (English, HTML) HTML